Papers of the Week

< BACK TO ARCHIVE

DATE PUBLISHED:
2023 Jan 13

JOURNAL:
Vaccine

PUBMED:
http://www.ncbi.nlm.nih.gov/pubmed/36658045?dopt=Abstract

Safety of primary immunization using inactivated SARS-CoV-2 vaccine (CoronaVac®) among population aged 3 years and older in a large-scale use: A multi-center open-label study in China.

Authors

Safety of primary immunization using inactivated SARS-CoV-2 vaccine (CoronaVac®) among population aged 3 years and older in a large-scale use: A multi-center open-label study in China.

Yang H, Li Z, Zhang R, Guo S, Wang B, Fang X, Zhang D, Zhang X, Tong Y, Wang Q, Deng Q, Sun Z, Liu X, Gao Y

Vaccine. 2023 Jan 13.

PMID: 36658045.

Abstract

To evaluate the safety of primary immunization using CoronaVac® among population aged 3 years and above in a large-scale use.

Read This Paper